Legal & General Group’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,064
Closed -$3K 3703
2022
Q1
$3K Hold
2,064
﹤0.01% 3542
2021
Q4
$7K Hold
2,064
﹤0.01% 3527
2021
Q3
$18K Buy
2,064
+494
+31% +$6.5K ﹤0.01% 3320
2021
Q2
$27K Buy
1,570
+123
+9% +$1.8K ﹤0.01% 3182
2021
Q1
$19K Buy
1,447
+343
+31% +$7.72K ﹤0.01% 3158
2020
Q4
$32K Hold
1,104
﹤0.01% 2932
2020
Q3
$33K Buy
+1,104
New +$33.5K ﹤0.01% 2819

Other funds holding AFIB

Legal & General Group's AFIB Position: Q2 2022 in Review

Legal & General Group sold out of Acutus Medical Inc (AFIB) in Q2 2022, closing a stake of 2,064 shares — an estimated $3K sold.

Legal & General Group first reported a position in AFIB in Q3 2020 and held it in 7 quarters. The position peaked at $33K in Q3 2020. 47 funds tracked by Wall St. Rank hold AFIB as of Q2 2022.

  • Legal & General Group reported no remaining Acutus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 2,064 Acutus Medical Inc shares in Q2 2022, an estimated $3K.
  • Legal & General Group first reported a position in Acutus Medical Inc in Q3 2020 and held it in 7 quarters.
  • Legal & General Group's Acutus Medical Inc position peaked at $33K in Q3 2020.
  • 47 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.